O'Carroll & Henshaw 2008 Aggregating Disparate Epi Evidence Risk Analysis 28(1)_ 225-234
-
Upload
anne-flynn -
Category
Documents
-
view
216 -
download
0
Transcript of O'Carroll & Henshaw 2008 Aggregating Disparate Epi Evidence Risk Analysis 28(1)_ 225-234
-
8/12/2019 O'Carroll & Henshaw 2008 Aggregating Disparate Epi Evidence Risk Analysis 28(1)_ 225-234
1/16
Risk Analysis, Vol. 28, No. 1, 2008 DOI:
10.1111/j.1539-6924.2008.01009.x
Aggregating Disparate Epidemiological Evidence:Comparing Two Seminal EMF Reviews
Michael J. OCarroll!and Denis ". #enshaw
$
Two seminal reviews I!"#$ 2002% #D&'$ 2002( o) *ossi+le ,eal,
e))es )rom*ower- )reen s rea,e*arl i))eren onlsions
)rom similar e*iemioloial eviene. T,ese i))erenes ,ave an im*a
on *reaionar *oli. 7e examine ,e saisial are- aion o)
resls )rom inivial is*arae sies. 7i,o onsisen ex*osre
meris$ -,e avanae o) mea-analsis o esimae manie o) e))e
is los. &owever$ onin *osi- ive an saisiall sini)ian resls
iels im*oran in)ormaion. T,is is no a s+sie )or mea-analsis$
+ a )all-+a w,en meanin)l mea-analsis is no availa+le. "e*resen-aive resls )rom 33 ine*enen al leemia sies a+le + I!"#
iele 23.5*os- iives p 0.01( an 9 sini)ian-*osiives p < 10(.
rom 43 re*resenaive resls )rom #D&'$ ,ere were 32 *osiive p oli +ase on ,e ris o) ,il,oo
leemia alone ens o +e limie +ease
,e normal iniene is om*araivel rare
an ,e ari+a+le ris ver small. T,e
esion o) aiional ris o) o,er iseases
,en +eomes im*or- an. &ene ,e#ali)ornia review$ + reoniCin )ive ,eal,
oomes orres*onin o ,e 2@ lassi)ia-
ion$ ,allenes ,e limiaion o)
*ro*orionae *re- aionar measres o
,ose o) ver low os.
-
8/12/2019 O'Carroll & Henshaw 2008 Aggregating Disparate Epi Evidence Risk Analysis 28(1)_ 225-234
4/16
4OCarroll and #enshaw
!n nersanin o) ,e i))erenes
+eween ,ese seminal reviews is ,ere)ore
im*oran o ,e *resen evelo*men o)
*reaionar*oli )or 4s.
$. T#E T'O SEM()A" EMF
#EA"T# RE,(E'S OF (ARC
A)D CD#S
@o, I!"# 2002( an #D&' 2002(
eval- ae ,e *ossi+le riss o *+li
,eal, )rom 4s a s**l )reen.
#D&' onsiere onl *ower- )reen
s$ w,ereas I!"# onsiere o,er
)reenies + s*ei)iall assesse *ower
)reen or ?(. I!"# assesse
arinoeni ris w,ereas #D&' assesse
+o, arinoeni an o,er ,eal,
oomes. Gever,eless$ ,e wo reviews ,a
a lare area o) ommon ron in ,e +oo) eviene re- lain o *ower-)reen
)iels an varios aner oomes.
T,e )ormaive wor )or I!"# 2002( was
arrie o a a 7orin Hro* meein in
ne 2001. T,e #D&' *roram exene
over several ears wi, #onsultation $ra%t &*+lis,e in !*ril 2001. I!"# 2002( i
no re)er o reen #D&' ra)s + i re- )er
o an earlier *roress review Gera et al.$
1996(. T,e )inal re*or o) #D&' 2002(
re)erre o I!"# 2001 in *ress( an
*arilarl aresse ,e es- ion o) ,eir
i))erin onlsions.
I!"# 2002( lise some 800 re)erenes$
over- in +o, ? mainl *ower-
)reen( an sai )iels. #D&' lise
some 400 re)erenes ? onl(.T,e I!"# lassi)iaion ssem )ormall
om- +ines assessmens o) eviene in
,mans esseniall e*iemiolo( an
eviene in animals. @o, reviews were aree
in assessin ,e eviene in animals as
Einae!uate.F ! *arilar i))il in
relaion o ,il,oo leemia is ,a
animal sies ol +e onsiere
ina**ro*riae +ease ,ere is no animal
moel )or ae lm*,o+lasi leemia$ ,eom- mon leemia *e in ,ilren. @o,
reviews were aree in assessin ,e
eviene in ,mans in rela- ion o
,il,oo leemia as Elimite,F an ,ene
were le + ,e )ormal lassi)iaion ssem o
-,e overall I!"# 2@ assessmen.
#D&' 2002( ses ano,er )ormal ssem
o) as- sessmen$ a E!ualitati'e (ayesF
a**roa,$ w,i, is a enral )eare o) ,e
review an an ineresin in- novaion.
&owever$ )or ,e *r*ose o) om*arison$,e also *rovie assessmens on ,e I!"#
lassi- )iaion ssem. T,e )ive ,eal,
oomes ieni)ie + #D&' as ea,
warranin I!"# 2@ lassi)iaion o) s
were ,il,oo leemia$ al leemia$
-
8/12/2019 O'Carroll & Henshaw 2008 Aggregating Disparate Epi Evidence Risk Analysis 28(1)_ 225-234
5/16
al +rain aner$ misarriae$ an
amoro*,i laeral slerosis !?'($ a
)orm o) moor nerone isease.
T,is arile om*ares ,e +ases o)
e*iemioloi- al eviene in ,e woreviews$ s*ei)iall )or al leemia an
al +rain aner. @o, reviews$ i- rel
or inirel$ onsier seleion an ali
o) sies$ an ,e e*iemioloial ,ol rini
o) ,ane$ +ias$ an on)onin a some
len,. 7e )in ,a ,e more maerial
i))erenes lie in ,eir a*- *roa, o
areaion ra,er ,an in ,e +o o) evi-
ene.
-. STAT(ST(CA"
A..RE.AT(O) OF
D(S/ARATE E,(DE)CE
FROM E/(DEM(O"O.(CA"
ST*D(ES
I is no nsal o )in a rane o)
reasona+l ine*enen e*iemioloial
sies$ ea, wi, is limiaions an
saisiall wea )inins$ + never- ,eless
wi, an overall enen o iniae a*ossi-+le e))e. One wa o) areain ,e
eviene )rom s, sies is + mea-
analsis or *oolin$ w,i, ma +e e)ine in
sli,l i))eren was.
T,is ,as ,e avanae o) esimain ,e
ma- nie o) an e))e an *roviin
on)iene lim- is )rom ,e areae
eviene. ', esimaes are mos
meanin)l w,en areain on a lie-
)or- lie +asis wi, rear o ex*osre meri$
s*ei)ii o) ases$ relevan s+ses o)*o*laion$ an s me,os.
'omeimes$ ,e eviene is more
is*arae$ so ,a onl limie nm+ers o)
similar sies an +e *oole o ive ver
meanin)l esimaes o)*aram- eers s, as
ris esimaes re*resenin manie o) a
*ossi+le e))e. or exam*le$ in ,e onex
o) $ ,e majori o) sies ,ave +een
onerne wi, ,e e))es o) ex*osre o
manei )iels. '- ies ma varaorin o *e o) ex*osre resi- enial$
o*aional($ s+ses o) *o*laion
ener$ rae$ ae$ sse*i+ili($ ex*osre
meri or *rox measremen$ *roximi$
jo+ ile$ averae$ *ea($ or ris measre
os raio or sanariCe iniene rae($an so on.
7,ile ain aon o) ,e aveas an
ali- )iaions relain o sini)iane an
,*o,esis es- in$ as issse$ )or
exam*le$ in "o,man an Hreenlan$ 1998$
,. 12($ i is never,eless *ossi- +le o
mae some assessmen o) ,e sren, o) a-
reae is*arae eviene. T,is ma +e
se)l in s**orin )ormal assessmen o)eviene$ in om- *arin i))eren
areae ses o) sies$ an in
-
8/12/2019 O'Carroll & Henshaw 2008 Aggregating Disparate Epi Evidence Risk Analysis 28(1)_ 225-234
6/16
om*arin i))eren onlsions rea,e+
review+oies.
@ Eis*araeF we mean eviene ,a
oes no reail s**or meanin)l mea-
analsis. @ im*li- aion ,is ma relae o a
+roa nerlin ,*o,- esis$ s, as a lass
o) ex*osres ,ro, varin meris
a))ein +ioloial ssems in i))eren was
amon i))erenl sse*i+le *o*laions
mani)es- in in a rane o) ,eal, oomes
s,owin onl wea assoiaions in ,e eneral
*o*laion. In ,is+roa sense Eis*ariF is
no neessaril ,e same as E,e- eroeneiF
as someimes evalae wi,in mea-
analsis. T,e *resen siaion is no so
+roa$ ,e main is*arae )eare+ein la
o) a well-e)ine ommon ex*osre meri$es*eiall )or o*aional ex*osre.
T,e wo reviews ea, aress a rane o)
i))er- en ,eal, oomes ,a mi, lea o
om*on ,*o,eses s, as asaion o)
+o, ,il,oo an al leemia or +o,
ae an ,roni($ or al- ernaivel o) one
an no ,e o,er$ + we s,all onsier ,em
more s*ei)iall$ as i ,e reviews. #D&'
i +rie)l aress ,e im*liaions )or one
oome o) )inins )or ano,er$ an ,e
I!"# eval- aion srre aresses ,e
arinoenii o) an aen ra-,er ,an
,*o,eses )or s*ei)i oomes$+ nei,er
review )ormlae or examine om- *on
,*o,esesper se.
T,is arile illsraes wo sim*le me,os
o) a- reaion: onin nm+ers o)
*osiive )inins an onin nm+ers o)
saisiall sini)ian-*osiive )inins. T,e
more is*arae ,e sies an )in- ins
onsiere$ ,e +lner ,e im*lie
,*o,esis$ w,ose neaion is ,e nll
,*o,esis ner examina- ion. or exam*le$
areain +o, resienial an
o*aional sies im*lies a ,*o,esis
,a +o, Eex*osresF are asal ris )aors
)or ,e s*ei)ie isease. T,a is more
emanin ,an a ,oie o) ei- ,er s,ar*er
,*o,esis wi, a more onsisen ex*o- sre.
I is no ,e *r*ose o) ,is arile o*rovie
a )ormal analsis o) s,ar*$ +ln$ an
om*on ,-*o,eses.'ome e*iemioloiss mi, )eel ,a s,
a sim- *le me,o o) areaion is oosim*lisi o on- sier an ,a
e*iemiolo ,as lon *roresse -o more
so*,isiae analses. &owever$ s,
sim*lis- i areaion is )namenal
saisiall an *ro- vies ,e sor o)
elemenar es ,a s,ol alwas +e
onsiere *rior o more so*,isiae
analsis$ es*eiall i) i iels an nex*ee
resl.
T,s$ ,ese onin me,os are no a
s+si- e )or mea-analsis or *oolin$ w,enavaila+le$+
-
8/12/2019 O'Carroll & Henshaw 2008 Aggregating Disparate Epi Evidence Risk Analysis 28(1)_ 225-234
7/16
an +e a )all-+a )or w,en ,e are no
availa+le. T,ese are iniaive$ ra-,er ,an
onlsive$ me,- os. Go all o) ,e saisial
in)ormaion is se. 4or exam*le$ ,e varin
siCe o) sies is los in on- in *osiiveresls. On ,e o,er ,an$ ,ere is some
im*orane o) i))eren sies w,en ,e are
ine- *enen. #onin sini)ian reslsoes re)le ,e saisial sren, o) ,e
)inins$ ,o, no ,e sa- isial *ower o)
,e sies$ so i *arl overomes ,e
*ro+lem o) )ailin o isriminae +eween
s- ies o) i))eren siCe an *ower. 7e o
no avoae ,ese me,os as a *anaea$
+ we o ses -,a in ,e a+sene o)
an,in +eer$ ,e s,ol no +e
overlooe. 7,a is sr*risin in ,is
insane is ,a ,ere is a similar nerlin
saisial sren, o) aa in +o, reviews$
*arl o+serve in one + seeminl
overlooe in ,e o,er.
0. .E)ERA" COM/AR(SO) OF
E,(DE)CE 1ASES FOR AD*"T
"E*%EM(A
I!"# selee an a+le resls
inlin os raio O"( or sanariCe
iniene raio 'I"( wi, on)iene
inerval #I( aa )rom 3 33 in- e*enen(
,man e*iemiolo sies )or al
leemia$ an #D&' i so )or 43. &owever$
es*ie ,e reviews;*+liaion in ,e same
ear an es*ie ,e ommon re)erene o
*revios reviews$ ,ese ses o) sies ,a
sr*risin i))erenes. @o, reviews ieni)
resienial an o*aional sies s*ei)io al leemia. I!"#;s 3 inle 6
resienial w,ereas #D&';s 43 onl inle
2 resienial.
T,e 43 sies lise + #D&' are erive
*rin- i*all )rom ,e same re)erene
sore =,ei)es et al.$ 199a(. O) ,e 41
o*aional sies$ 1 are inle in ,e
I!"# a+les )or al leemia$ 18 are no
o) w,i, 5 are$ ,owever$ lise in I!"#;s
re)erenes($ an ,e o,er 6 re)er o similarsies + ,e same a,ors e..$ wi,
i))eren aes($ so ma overla*.
O) ,e 32 o*aional sies onsiere
+ I!"#$ a)er ein 1 ommon an 6
similar sies$ ,ere remain 9 ,a are no
in #D&'. O) ,e 6 resienial sies lise+ I!"# Ta+le 25($ onl 1 'everson 1998(
is lise in ,e #D&' a- +le )or al
leemia. T,e seon resienial s lise
+ #D&' is o) 7er,eimer an ?ee*er$
1982($ w,i, is no in I!"#;s Ta+le 25.
O) ,e 41 o*aional sies lise +
#D&'$ ,ere are wo ses o) mli*le sies
)rom ,e same sore -,ree )rom T,erial
et al. 1994( an wo )rom Tnes et al.
1994(% ,e +i+liora*, liss wo
-
8/12/2019 O'Carroll & Henshaw 2008 Aggregating Disparate Epi Evidence Risk Analysis 28(1)_ 225-234
8/16
-
8/12/2019 O'Carroll & Henshaw 2008 Aggregating Disparate Epi Evidence Risk Analysis 28(1)_ 225-234
9/16
Ta2le (. !reaion o) ,e !l ?eemia !?( 'ies #onsiere+#D&' 2002(
#D&'/!? 1 *er '( Go. o) O"s >osiives *-ale )or >osiives 'ini)ian->osiives *-ale )or 'i-
"esienial 2 2 0. 1 0.0
O*aional 4 3 0.0 1 1
10
11
Toal 4 3 0.0 1 11012
One-sie osiives *-ale )or 'i->os
"esienial 4 3 0.06L0.31 2 0.0036#o,or o*aional 4 4 0.0625 2 0.0036
#ase-onrol o*aional 5 4 0.185 2 0.0059
Toal 1 1 0.002L0.01 6 3.6
sini)ian-*osiives an no sini)ian-neaives. T,e
p-vales are 0.34 )or ,e *osiives an 0.11 )or -,e
sini)ian-*osiives. 'eleion o) ,i,-ex*osre re-
sls oes no s+saniall ,ane ,e *ire. T,ese
sies o no ive ,e same in o) messae as ,e
manei )iel resls.
4. COM/AR(SO) OF RE,(E'S FOR AD*"T
1RA() CA)CER
#D&' aain aresses ,e esion o) area-
ion$ iin 32 sies )or al +rain aner in Ta+le
9.1.1 o) ,eir s$ om*risin 29 )or o*aional
an 3 )or resienial ex*osres$ an lisin one re*re-
senaive resl )or ea, s O" or o,er ris mea-
sre$ wi, on)iene limis(. #D&' re)ers o a mea-
analsis + =,ei)es o) ,e 29 o*aional sies
wi, overall O" o) 1.2 95K #I: 1.1L1.3( an o nm-
+ers o) *osiive resls an nm+ers wi, O" a+ove
1.2. #D&' i no on nm+ers o) sini)ian re-sls.
In Ta+le 9.2.2 #D&' inles aiional s-
ies o ,e 32 in Ta+le 9.1.1 + ives on)iene iner-
vals )or onl 5 o) ,em. One s om+ines resien-
ial an o*aional ex*osre$ an one is )or ele-
ri )iels wi, a sini)ian *osiive resl(. 7,ile
#D&' issses ,ese aiional seven sies$ -,e
are no inle in is areaion an mae lile
overall i))erene o i(. Or smmar )or ,e 32 ie
sies is iven in Ta+le I.
7,ile ,ese areaions are no as sron as
,ose )or al leemia$ ,e are ,i,l sini)ian.I!"# seles 38 sies wi, +rain aner resls
)or sein o in is main a+les$ o) w,i, 5 are res-
ienial Ta+le 26($ 15 are o*aional o,or s-
ies Ta+le 29($ an 18 are o*aional ase-onrol
sies Ta+le 30(. T,e res*eive nm+ers o) resls
wi, ris measres an on)iene inervals are 24$
32$ an 53$ ,a is$ 109 in all$ + ,ese inle re*-
eiion o) s+*e resls in oals an inle low-
ex*osre as well as ,i,er-ex*osre resls )rom -,esame sies.
T,ese inle wo sies '*inelli$ 1995% "on-
ne+er et al.$ 1999( ,a are )or ex*osres o sai
manei )iels. T,e wol ,ave +een +eer ex-
le w,en assessin resls )or ? *rini*all
*ower-)reen( )iels$ as ,e wo ex*osres are
ie i))eren. &owever$ ,e #D&' liss also in-
le one o) ,ese sies$ '*inelli 1995($ wi,
resls )or +o, +rain aner *osiive( an )or
leemia neaive(. I!"# inles ,ese *ls -,e
neaive resls )rom "onne+er et al. 1999(. In
reain #D&' an I!"# om*ara+l$ ,ese ina*-
*ro*riae resls are ,ere le) in. T,e e))e is sli,$+
wa o) ilin an overall )inins.
O) ,e 109 re resls$ 1 are *osiive an 16 are
sini)ian-*osiive. T,a wol +e ,i,l sini)i- an
ner a nll ,*o,esis )or a ranom sam*le o)
ine*enen resls. T,ere are also ,ree sini)ian-
neaive resls$ ea, wi, ,e **er on)iene limi
js on 1.0. T,a wol no +e remara+le ner a
nll ,*o,esis )or 109 ine*enen resls p =0.51($ + ol +e ner a sroner alernaive es
,*o,esis wi, a *osiive assoiaion.
One sini)ian-neaive resl is )or a low-
ex*osre aeor resienial s in Ta+le 26% -,a-s is elare )or Enervos ssemF aner ra-,er
,an +rain anerper se+ i is inle in Ta+le 26$
Ta2le (,. !reaion o) 'ies o) !l @rain #aner in #D&' 2002(
#D&'/@rain 1 *er '( Go. o) O"s or "is >osiiv *-ale )or 'ini)ian- *-ale )or 'i-
"esienial 3 2 0 0 1O*aional 2 2 0.0 6 10
5
Toal 3 2 0.0 6 0.00
-
8/12/2019 O'Carroll & Henshaw 2008 Aggregating Disparate Epi Evidence Risk Analysis 28(1)_ 225-234
14/16
14OCarroll and #enshaw
Ta2le ,. !reaion o) 'ies o) !l @rain #aner in I!"# 2002( on ,e @asis o) 'eleion #rieria o Ieni) One "e*resenaive
"esl *er 'I!"#/@rain 1 *er '(Go. o) O"s>osiives
*-ale )or >osiives'ini)ian >osiives
*-ale )or 'i->os
"esienial 5 3 0.5 0 1#o,or o*aional 9 0.15L0.3 3 0.005
#ase-onrol o*aional 0.15 3 0.005
Toal 35
22.
0.04L0.09 6 0.0002
w,i, is )or +rain aner. T,e o,er wo sini)ian-
neaives are in Ta+le 29 an are )or males$ w,ile
,e are aom*anie + nonsini)ian-*osiives )or
)emales% ,e seleion rieria ,ose ,e more *o*-
los males$ ,o, i) males an )emales were om-
+ine ,e sini)iane wol +e los. One sini)ian-*osiive resl was similar + ,e o,er wa ron$
+ein js sini)ian-*osiive )or males alonsie a
nonsini)ian-neaive )or ,e less *o*los )e-
males. 'ome sini)ian-*osiives lise )or #oo et al.
1999( in Ta+le 30 ma loo ss*iios a )irs si,$
as ,ree are re*ore as ,avin O" as 1.2 95K #I
= 1.1L1.2($ w,i, seems o + ol +e
aone )or + ron-o)) )rom$ )or exam*le$
1.1 1.11L1.24( onsisen wi, ,e sal lo-normal
moel.
!**lin or seleion rieria o+ains a more in-
e*enen se o) resls$ a mos one *er s$ al-
,o, as noe a+ove i seles more *o*los male
sies ,a wol +e *arl onere + )emale
sies. One s remaine am+ios an o))ere
alernaive o**osie resls o) )airl eal wei, in
Ta+le 29$ ,e 4loers et al. 1994( s o) enine
rivers or railwa worers )rom ,e 1960s or 190s(% i
was re*resene ,ere as ,al) *osiive an ,al) ne-
aive. T,e resl o) selein one resl *er s is
smmariCe in Ta+le .
! ,is *oin ,e seleion *roess ,as real
weaene ,e areae eviene$ larel +ease so
man sroner resls were in s+ses. T,e selee
eviene remains sini)ian$ i) marinall so$ ans,ol no +e ismisse$ al,o, i wol no ,ave
,e same saisial wei, in assessmen as ,a )or
al leemia. In aiion$ ,e sini)iane o) ,e
nm+er o) sini)ian-*osiive resls is em*ere +
,e exisene o) ,ree marinal sini)ian-neaives
in ,e re aa se$ wo o) w,i, srvive seleion o)
one resl *er s.
!**lin ,e exra se o) seleion rieria loses
even more sren, o) eviene$ as so man o) ,e+rain aner sies o no ,ave an ex*osre as-
sessmen in erms o) )iel sren,. T,e resl$ in
Ta+le I$ ,as now los sini)iane$ +earin in min
,a one sini)ian-neaive resl was also selee.
5. COM/AR(SO) '(T# E,(DE)CE O)
C#("D#OOD "E*%EM(A
T,e same a**roa, o areaion ma +e a*-
*lie o ,e #D&' se o) 19 sies )or ,il,oo
leemia lise in Ta+le 8.1.2. !s wi, o,er ,eal,
oomes$ #D&' a**lies is Esin esF an o+serves
,e 16 *osiive resls o o) 19$ iinp= 0.0004 al-
,o, or mlaive+inomial allaion )or 16 or
more o o) 19 ivesp= 0.002. #D&' oes no on-
sier ,e nm+er o) sini)ian resls 3 o o) 19%p
= 0.01(. T,ere were no sini)ian neaive resls
an no resls )or O" or #?s rnae o 1.00.
I!"# a+les eaile resls )or ,il,oo
leemia )or 14 ,il,oo leemia sies in Ta+les
18$ 19$ an 23$ om*risin 10 resienial ex*osre
sies an 4 relain o se o) omesi a**lianes.
!**lin ,e same *roesses as )or al leemia$
we )in o o) 14 resls one *er s( ,ere are
13 *osiive an 3 sini)ian-*osiive resls$ wi, p-vales o) 0.0009 an 0.005$ res*eivel.
On ,is assessmen o) ,e vale o) ,e lise ses o)
sies$ ,e eviene )or al leemia a**ears
Ta2le ,(. !reaion o) 'ies o) !l @rain #aner in I!"# 2002( on ,e @asis o) 'eleion #rieria o Ieni) "esls wi,
#om*ara+le 2x*osres
I!"# / @rain 'ele "esls( Go. o) O"s >osiives *-ale )or >osiives 'ini)ian >osiives *-ale )or 'i->os
"esienial 5 3 0 0 1#o,or o*aional 4 3 0 2 0.0036
#ase-onrol o*aional 5 3 0 0 1
Toal 1 9 0 2 0.04
-
8/12/2019 O'Carroll & Henshaw 2008 Aggregating Disparate Epi Evidence Risk Analysis 28(1)_ 225-234
15/16
more sini)ian ,an ,a )or ,il,oo leemia.
&owever$ we ,ave no aen ino aon onsis-
en o) ex*osre *e or measremen$ or mani-
e o) a**aren e))e s, as re*resene + O"s.
#D&' re)ers o 7aren+er 2001($ wi, a mea-
anali smmar O" o) 1.3 1.0L1.( )or ,il,ooleemia. T,is mi, reasona+l +e om*are wi,
,e mea-anali smmaries ie )or al leemia
o) 1.2 1.12L1.24( an )or +rain aner o) 1.2 1.1L1.3(
wi, re)erene o =,ei)es et al. 199a(. T,ere is no
m, i))erene+eween all ,ree aner ro*s a-
,is level o) mea-analsis.
T,e wo-*oole analses )or ,il,oo
leemia$ wi, O"s o) 1.69 1.25L2.29( )or ex-
*osres a+ove 0.3 "T + Hreenlan et al. 2000( an
2.00 1.2L3.13( )or ex*osres a+ove 0.4 "T +
!,l+om et al. 2000($ *rovie sroner resls +
)osin on )ewer more o,eren an om*ara+le
sies. !l,o, ,e al leemia an +rainaner sies ma +e more is*arae ,an ,ose
enirel resienial sies *oole )or ,il,oo
leemia$ i wol seem *lasi+le ,a i) ,e ,a
+eer ex*osres measremens ,a ol +e se
)or seleion$ ,e resl wol also +e o sren,en ,e
overall )inin.
6. CO)C"*S(O)S
T,ere is a ris ,a review +oies$ ,owever a-
s$ ma overloo ,e saisial wei, o) are-
ae eviene in a olleion o) is*arae sies,a are iniviall inonlsive. I wol +e ,el*- )l
in im*rovin on)iene in ,eir reviews an as-
sessmen eisions i) ,e isse o) areaion o) is-
*arae eviene ol +e seen o +e aresse ex*li-
il$*re)era+l + a )ormal *oole analsis or mea-
analsis o ive an overall ris esimae$ or i) ,a is no
availa+le$ a leas + ,e sor o) sini)iane anal- sis
,a we ,ave emonsrae in ,is arile.
In areain eviene + ,e sim*le sini)i-
ane analsis we illsrae$ w,en sin ,e Esin
esF onin nm+ers o) *osiive resls($ os ra-
ios re*ore as rnae a 1.0 or 1.00 e. s,ol+e
one as ,al) *osiive an no isone. #on-
in nm+ers o) sini)ian resls in ,is ase ives
sroner in)ormaion ,an ,e sim*le sin es. I) s-
in ,e mlaive +inomial isri+ion o assess
,e sini)iane o) nm+ers o) *osiive resls or o)
sini)ian-*osiive resls$ i is im*oran ,a ,e in-
ivial resls are ine*enen. 7e ,ave sese a
se o) seleion rieria o *roe a mos one re- sl
*er s )or ,is *r*ose. &owever$ one isa-
vanae o) ,is a**roa, is ,a a eninel raise
ris in a*arilar aner s+*e ol +eome los in
onsierin all s+*es in one ro*$ )or exam*le all
leukemia$ or all brain cancer.
T,e #D&' ,as aresse ,e areaion o) re-
sls$ sin ,e sin es an re)errin o exernal
mea-anali smmaries$ + i ,as no onsiereons o) sini)ian resls. T,e I!"# review s,ows
no eviene o) ,avin onsiere ,e areaion o)
resls o,er ,an s+jeivel. I ,as onsiere in-
ivial sies in eail an ieni)ie ,eir s,or-
omins$ + ,is ,as le o a enen o )ramen an
ismiss eviene ,a is inrinsiall ,i,l si-
ni)ian.
"eview +oies ,ave a ri, o ismiss eviene on
raional rons$ ain ino aon *oenial+ias$
on)onin$ an me,ooloial limiaions$ as well
as saisial sren,$ + s,ol no o so wi,- o
+ein seen also o ae saisial areaion ino
aon.
T,e #D&' review o))ers a se)l om*lemen-
ar insi, ino ,e wei, o) e*iemioloial evi-
ene in ,man sies. I as a *ers*eive ,a ,e
mainsream inernaional review +oies seem
o ,ave overlooe.
T,e i))erenes in ,e onlsions o) ,e I!"#
an #D&' reviews are no ex*laine+ i))erenes in
,e ses o) sies ,e onsiere. T,eir over- la**in
aa ses on al leemia$ w,ile sr*ris- inl
i))eren in ,e sies inle$ +o, re*resen a
,i,l sini)ian +o o) areae eviene. In ,e
ase o) +rain aner$ ,e re ses o) aa +o,a**ear ,i,l sini)ian in areae$ ,o, or se-
leion rieria a**lie o ,e I!"# aa *roe
onl a marinall sini)ian areae resl.
I is e+aa+le w,e,er ,e I!"# lassi)iaion
ssem s,ol +e se o isinis, +eween s*e-
i)i iseases$ sine i seems o +e esine o lassi)
aens. I wol +e reasona+le )or ,e I!"# lassi)i-
aion o re)er o eviene on ,il,oo leemia in
rea,in a 2@ lassi)iaion. T,e aiional eviene
on al leemia an +rain aner mi, ,en a
)r,er s**or$ w,en aen in aiion o ,il,oo
leemia.
@ se*arain ,e eviene in ,mans )or Eall
o,er anersF +esies ,il,oo leemia( an
smmaril lassi)in i as EinaeaeF 'eion 5.5$
*. 338( I!"# ma +e seen as e))eivel *romoin a
,*o,esis ,a s ma +e a ase o) ,il,oo
leemia alone an o) no o,er aners. T,a is ,ow we
see*olimaers iner*rein i. 7e o no ,in ,is is
raional )or om*lex mliasal iseases$ es-*eiall
+earin in min eviene )or *ossi+le ss- emi
e))es ,a ol a))e asaion o) several
-
8/12/2019 O'Carroll & Henshaw 2008 Aggregating Disparate Epi Evidence Risk Analysis 28(1)_ 225-234
16/16
$-0OCarroll and #enshawiseases. I!"# oes no seem o ,ave aresse -,e
esion o) om*on ,*o,eses.
T,is exlsive ari+ion o) ,e I!"# 2@ las-ress ,e im*a o) *ossi+le ,eal, oomes
o,er ,an ,il,oo leemia$ noin es*e- iall ,eir relaivel ,i, iniene om*are
si)iaion o ,il,oo leemia ,as re*erssions in*reaionar *oli$ as mani)es in ,e ra) 7&O
>reaionar 4ramewor 2006(. Owin o is rari$
,il,oo leemia ,as relaivel lile im*a on so-
ie an is avoiane ,ere)ore ,as relaivel lile
+ene)i$ om*are wi, ,e s+saniall more *reva-
len al leemia an +rain aner$ as well as -,e
o,er oomes rae as 2@ + #D&'.
!n earlier review + ,e GI&' 1999( ,a as-
soiae +o, al an ,il,oo leemia wi, a
2@ lassi)iaion$ an +o, ,e I!"# an #D&' re-
views were in)orme+ ,is. Hiven ,e exen an a-
reae sren, o) ,e eviene )or al leemia$
+o, in isel) an in om*arison wi, ,a )or ,il-
,oo leemia$ i is i))il o see a lear ivision ,a
wol s**or an exlsive ,*o,esis o) ar-
inoenii o) s )or ,il,oo leemia + no
)or al leemia.
/ostscript: 'ine or )irs wriin o) ,is arile$
,e s + ?owen,al et al. 200( ,as a**eare$ as
,as or ommenar in ,e same jornal O;#arroll
an &ens,aw$ 200(. T,ese resls rein)ore or on-
lsions in res*e o) al leemia$ ,o, or ar-
men is *rini*all a+o me,oolo.
!7. RECOMME)DAT(O)S
T,e )ollowin reommenaions are mae )or )-
re reviews o) ,eal, e))es.
i( I!"# an o,er review +oies s,ol inor-
*orae ex*ressl ino ,eir me,oolo some
assessmen o) areae vale o) is*arae evi-
ene. ', assessmen s,ol no isel) eer-
mine ,e overall assessmen eision$ + i is
+e--er o +e aware o) ,e nare o) ,e are-
ae aa.
ii( ! )ose *oole analsis s,ol +e ner-
aen )or al leemia o *arallel$ as )ar as
*ossi+le$ ,ose o) !,l+om et al. an Hreenlan
et al. )or ,il,oo leemia.
iii( !visor +oies onsierin *reaionar
*oli relain o s s,ol ae ino a-
on +o, ,e I!"# an #D&' reviews$ in-
lin ,e )ailre o) I!"# o emonsrae
an assessmen o) areae vale o) eviene.
iv( T,e 7&O eam$ in )ormin is >re-
aionar 4ramewor$ s,ol ex*ressl a-
wi, ,il,oo leemia$ an ivin*ari-lar aenion o ,e )ive oomes lassi)ie+
#D&' as orres*onin o I!"# #lass 2@.
AC%)O'"ED.ME)TS
7e ,an #,ilren wi, ?eemia ro-ram$ inal "e*or- ne 2002.
Hreenlan$ '.$ ',e**ar$ !. ".$ =ane$ 7. T.$ >oole$ #.$ M =els,$. !. 2000(. ! *oole analsis o) manei )iels$ wire oesan ,il,oo leaemia.,piemiology$ 11$ 624L634.
I!"#. 2002(. I!"# monora*,s on ,e evalaion o) arino-eni riss o ,mans$ vol. 80$ Gon-ionisin raiaion$ *ar 1:'ai an exremel low )reen ?4( eleri an ma-nei )iels$ I!"# >ress$ 2002.
?owen,al$ ". .$ T$ D. .$ M @ra$ I. #. 200(. "esien- ialex*osre o eleri *ower ransmission lines an ris o)lm*,o*roli)eraive an melo*roli)eraive isorers: ! ase-onrol s.nternal eicine +ournal$ &/$ 614L619.
Gaional Insie o) nvironmenal &eal, 'ienes GI&'(.
1999(. GI&' re*or on ,eal, e))es )rom ex*osre -o*ower-line )reen eleri an manei )iels. GI& >+li-aion Go. 99-4493$ >. O. @ox 12233$ "esear, Trianle >ar$
G#..
O;#arroll$ . .$ M &ens,aw$ D. ?. 200(. ?eer o ,e eior:!l leaemia near *owerlines. nternal eicine +ournal$&/$ 841.
"o,man M Hreenlan. 1998(. oern ,piemiology$ 2n e.>,ilael*,ia$ >!: ?i**ino$ 7illiams M 7ilins.
7&O 4ramewor Hiin >+li &eal, >oli O*ions in !reaso) 'ieni)i arilar "e)erene o 4s.Dra) )or #onslaion$ a 2006. T,e Inernaional 24>roje "aiaion an nvironmenal &eal,